Teladoc Health, Inc. (NYSE:TDOC) Receives Average Recommendation of “Hold” from Analysts

Teladoc Health, Inc. (NYSE:TDOC) has been assigned a consensus recommendation of “Hold” from the nineteen brokerages that are currently covering the firm, MarketBeat.com reports. Twelve research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $9.7639.

Several equities analysts have weighed in on TDOC shares. Bank of America dropped their price objective on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a report on Wednesday, May 28th. The Goldman Sachs Group lowered their price target on Teladoc Health from $13.00 to $10.00 and set a “buy” rating for the company in a report on Thursday, May 1st. Stifel Nicolaus lowered their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, May 1st. Truist Financial lowered their price target on Teladoc Health from $10.00 to $9.00 and set a “hold” rating for the company in a report on Tuesday, May 27th. Finally, Mizuho began coverage on Teladoc Health in a report on Friday, July 25th. They set a “neutral” rating and a $10.00 price target for the company.

Insiders Place Their Bets

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,808 shares of the company’s stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the completion of the transaction, the insider owned 69,773 shares of the company’s stock, valued at $478,642.78. This represents a 7.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Carlos Nueno sold 3,958 shares of the company’s stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider directly owned 17,645 shares of the company’s stock, valued at approximately $121,044.70. The trade was a 18.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 18,656 shares of company stock valued at $128,189 in the last 90 days. Corporate insiders own 0.58% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its position in shares of Teladoc Health by 7.0% in the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock valued at $157,229,000 after buying an additional 1,289,183 shares during the last quarter. Point72 Asset Management L.P. grew its position in shares of Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider’s stock valued at $101,625,000 after buying an additional 2,813,568 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Teladoc Health by 2.1% in the 2nd quarter. Geode Capital Management LLC now owns 4,150,197 shares of the health services provider’s stock valued at $36,153,000 after buying an additional 84,356 shares during the last quarter. Maple Rock Capital Partners Inc. grew its position in shares of Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock valued at $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Teladoc Health by 0.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider’s stock valued at $32,104,000 after buying an additional 8,890 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $7.29 on Friday. The stock has a market capitalization of $1.29 billion, a PE ratio of -6.12 and a beta of 1.76. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58. The business has a fifty day moving average price of $7.71 and a two-hundred day moving average price of $8.34. Teladoc Health has a fifty-two week low of $6.35 and a fifty-two week high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.08. The firm had revenue of $631.90 million during the quarter, compared to analysts’ expectations of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%. The company’s quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.38) EPS. As a group, equities analysts predict that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.